APA (7th ed.) Citation

PW, W., PD, B., MK, M., PD, R., A, M., CL, D., . . . W, A. (2022). Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy. JCO precision oncology, 6, e2200197. https://doi.org/10.1200/PO.22.00197

Chicago Style (17th ed.) Citation

PW, Whitworth, et al. "Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy." JCO Precision Oncology 6 (2022): e2200197. https://doi.org/10.1200/PO.22.00197.

MLA (9th ed.) Citation

PW, Whitworth, et al. "Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy." JCO Precision Oncology, vol. 6, 2022, p. e2200197, https://doi.org/10.1200/PO.22.00197.